Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

225

HTML

1826

Figures (1-2)

190

Tables (1-2)

165

Sum=2406

Sep 28, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 28, 2005; 11(36): 5685-5687
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5685

Table 2 Evaluation of IFNα /5-FU combination therapy

	Evaluation after 1^st cyclepatient n (%)	Final resultspatient n (%)
CR		1 (3.6)
PR	16 (57.1)	5 (17.9)
NR	12 (42.9)	22 (78.6)

IFN, interferon; FU, fluorouracil; CR, complete response; PR, partial response; NR, no response.

Citation: Enjoji M, Morizono S, Kotoh K, Kohjima M, Miyagi Y, Yoshimoto T, Nakamuta M. Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma. World J Gastroenterol 2005; 11(36): 5685-5687
URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5685.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5685